Phase 1
Ended Awarded Last action
- Contract number
- HHSN27200002
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $63,416
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $63,415.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$150,022 | |
| Original award | $213,438 |
Quick answers
Who was awarded contract HHSN27200002?
HHSN27200002 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 14, 2015.
How much is contract HHSN27200002 worth?
The government has obligated $63,416 on HHSN27200002.
Is contract HHSN27200002 an order under another contract?
Yes. HHSN27200002 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200002 competed?
The extent of competition for HHSN27200002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award